Terry Lierman
Directeur/Membre du Conseil chez IGC PHARMA, INC.
Fortune : 14 323 $ au 31/05/2024
Profil
Terry Lierman is the founder of Pancreatic Cancer Action Network, Inc. He is currently the Director at Profectus BioSciences, Inc. and an Independent Director at IGC Pharma, Inc. In the past, he worked as a Director at WellDoc, Inc. and as a Staff Director at the National Institutes of Health.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IGC PHARMA, INC.
0,04% | 13/03/2024 | 29 411 ( 0,04% ) | 14 323 $ | 31/05/2024 |
Postes actifs de Terry Lierman
| Sociétés | Poste | Début |
|---|---|---|
| IGC PHARMA, INC. | Directeur/Membre du Conseil | 12/03/2024 |
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Directeur/Membre du Conseil | - |
Anciens postes connus de Terry Lierman
| Sociétés | Poste | Fin |
|---|---|---|
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Fondateur | - |
WellDoc, Inc.
 WellDoc, Inc. Packaged SoftwareTechnology Services WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IGC PHARMA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
WellDoc, Inc.
WellDoc, Inc. Packaged SoftwareTechnology Services WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD. | Technology Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Health Services |
